Generate a tailored SOP for Dr. David Rimm. Improve your application with a focused, well-structured draft.
David Rimm is the Anthony N. Brady Professor in the Department of Pathology and Medicine (Medical Oncology) at Yale University School of Medicine. He completed his MD-PhD at Johns Hopkins University and underwent pathology residency and cytopathology fellowship. Rimm leads a research group that focuses on quantitative pathology using AQUA® technology, which was invented in his lab, and emphasizes predicting response and resistance to targeted immunotherapy in cancer. His lab explores new high-plex methods for digital spatial profiling and is involved in biomarker discovery. Rimm's work has been supported by grants from the NIH and BCRF, and he serves on multiple scientific advisory boards in biotechnology and pharmaceuticals. He has authored over 500 peer-reviewed papers, with an H-index of 120 and 8 patents. His specialized interests include the development of standardized assays for antibody-drug conjugate therapies and innovative research in biospecimen science. He is also known for the AQUA method to improve the analysis of immunohistochemistry and has published extensively in prominent journals.
Yale University School of Medicine • New Haven, CT
Anthony N. Brady Professor in the Department of Pathology and Medicine (Medical Oncology).
Yale Cancer Center Tissue Microarray Facility • New Haven, CT
Yale Pathology Tissue Services • New Haven, CT
Physician Scientist Training Program • New Haven, CT
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.